GamTBvac

recombinant subunit tuberculosis vaccine · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GamTBvac, covering 2020-06-17 to 2022-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac [Phase 3]